About 2,190 results
New AI Tool Offers Detailed Cancer Prognosis and Recurrence …
Phase 3 Trial of Tafasitamab in Follicular Lymphoma Meets …
FDA-Approved and Investigational TRK Inhibitors - Targeted …
FDA Acknowledges BLA of Zolbetuximab in HER2–, CLDN18.2
Enzalutamide Demonstrates Long-term Overall Survival in mHSPC
Nadofaragene Firadenovec Continues to Demonstrate Durable …
Treating Squamous vs Nonsquamous Disease - Targeted Oncology
Actionable Mutations Playing and Increasingly Important Role in …
Progression After R-CHOP: What Next? - Targeted Oncology
Exposure to Agent Orange Associated With Increased Prevalence …